Streetbeat News

Equity Actions

SPY

The S&P 500 Index has recently achieved seven consecutive sessions of positive gains. According to an analysis by Ryan Detrick, a 7-day winning streak for the S&P 500 has historically indicated above-average returns in the following months. However, the three most recent 7-day winning streaks in 2021 led to negative one-year returns. On average, since 1990, the S&P 500 has seen a 10.3% increase in the year following a 7-day winning streak.

Portfolio Pulse from Piero Cingari

November 08, 2023 | 8:37 pm

HNRA

HNR Acquisition has filed a registration statement to register approximately 1.3 million shares that were issued prior to its IPO. This move is aimed at facilitating the approval of its listing with the New York Stock Exchange (NYSE).

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 8:22 pm

LRCX

Deep-pocketed investors have shown a bearish sentiment towards Lam Research (NASDAQ:LRCX), with significant options moves detected. Benzinga's options scanner highlighted 10 extraordinary options activities for Lam Research, with 80% of these investors leaning bearish. The major market movers are focusing on a price band between $475.0 and $700.0 for Lam Research. Analyst ratings for Lam Research include JP Morgan's Overweight rating with a target price of $700, B. Riley Securities' Neutral rating with a target price of $700, and Needham's upgraded rating to Buy with a revised price target of $800.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 8:22 pm

COTY

DA Davidson analyst Linda Bolton Weiser reiterated a Buy rating on Coty Inc (NYSE:COTY) and raised the price target from $15 to $17. Coty reported Q1 FY24 sales growth of 18% YoY to $1.64 billion, beating the consensus estimate of $1.58 billion. E-commerce sales were up more than 25% YoY. Coty issued 33 million shares to facilitate ownership by European investors and build liquidity in Europe. The company expects to repurchase 27 million shares in Q3. FY24 is expected to be the third consecutive year of double-digit organic sales growth and EBITDA growth of 8% or higher.

Portfolio Pulse from Shivani Kumaresan

November 08, 2023 | 8:16 pm

ZS

A significant amount of unusual options activity has been observed for Zscaler (NASDAQ:ZS), with a split sentiment between bullish and bearish. The trading activity suggests that significant investors are aiming for a price range of $140.0 to $240.0 for Zscaler over the next three months. Jefferies has upgraded their rating to Buy and adjusted the price target to $225, while JMP Securities downgraded its action to Market Outperform with a price target of $225.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 7:16 pm

CRWD

A financial giant has made a bearish move on CrowdStrike Holdings (NASDAQ:CRWD), with 63% of traders showing bearish tendencies. The major market movers are focusing on a price band between $50.0 and $230.0 for CrowdStrike Holdings. Argus Research downgraded its rating to Buy, setting a price target of $220. JMP Securities revised its rating downward to Market Outperform, adjusting the price target to $235. Jefferies upgraded their rating to Buy and adjusted the price target to $225.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 7:15 pm

PFE

A significant bearish move has been observed in Pfizer's (NYSE:PFE) recent unusual options activity. Analysis revealed 70% of traders showed bearish tendencies, with 7 puts valued at $8,504,440 and 3 calls valued at $80,240. Major market movers are focusing on a price band between $20.0 and $50.0 for Pfizer. Trading volume stands at 13,151,033, with PFE's price down -2.0%, positioned at $30.62. Analysts from Barclays, UBS, Citigroup, JP Morgan, and Wells Fargo maintain neutral to equal-weight ratings on Pfizer with target prices around $34-$35.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 7:02 pm

CIFR

Cipher Mining has filed for an offering of 2.4 million shares of its common stock directly to Trinity Mining Group. The offering is pursuant to the prospectus supplement.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 6:54 pm

CLDX

Celldex Therapeutics announced a proposed public offering of 7.425 million shares at $27 per share, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 6:06 pm

DIS

Disney is in talks with the NFL and NBA about them taking an equity stake in ESPN, which is valued between $25 billion and $30 billion. This comes as Disney is under pressure from Wall Street to improve results.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 6:05 pm